Literature DB >> 8654672

Effects of endotoxin on lipid metabolism.

I Hardardóttir1, C Grunfeld, K R Feingold.   

Abstract

Endotoxin, via cytokines, induces marked changes in lipid metabolism which are now considered part of the acute phase response. The endotoxin induced hyperlipidemia may represent a nonspecific immune response that can decrease the toxicity of a variety of harmful biological and chemical agents and serve to redistribute nutrients to cells important in host defense. The endotoxin induced changes in lipid metabolism may therefore be beneficial.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8654672     DOI： 10.1042/bst0231013

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


  14 in total

1.  Innate and acquired immunity intersect in a global view of the acute-phase response.

Authors:  Joo-Yeon Yoo; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

2.  Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.

Authors:  Min Sun Kim; Trevor R Sweeney; Judy K Shigenaga; Lisa G Chui; Arthur Moser; Carl Grunfeld; Kenneth R Feingold
Journal:  Metabolism       Date:  2007-02       Impact factor: 8.694

3.  Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon.

Authors:  Benjamin J Visser; Sophia G de Vries; Rieke Vingerling; Martin Gritter; Danielle Kroon; Lídia Ciudad Aguilar; Rik B J Kraan; Rosanne W Wieten; François Danion; Barbara Sjouke; Akim A Adegnika; Selidji T Agnandji; Peter G Kremsner; Thomas Hänscheid; Petra F Mens; Michèle van Vugt; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

4.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

5.  LDL apheresis as an alternate method for plasma LPS purification in healthy volunteers and dyslipidemic and septic patients.

Authors:  Auguste Dargent; Jean-Paul Pais de Barros; Samir Saheb; Randa Bittar; Wilfried Le Goff; Alain Carrié; Thomas Gautier; Isabelle Fournel; Anne Laure Rerole; Hélène Choubley; David Masson; Laurent Lagrost; Jean-Pierre Quenot
Journal:  J Lipid Res       Date:  2020-10-09       Impact factor: 5.922

6.  A negative association between low-density lipoprotein cholesterol level and infection risk in elderly stage 5 chronic kidney disease patients.

Authors:  Ping Liu; Shuying Zhang; Lijuan Jiang; Jinhong Ma; Xiaonan Shao
Journal:  Clin Exp Nephrol       Date:  2021-09-14       Impact factor: 2.801

7.  Gene expression profiles characterize inflammation stages in the acute lung injury in mice.

Authors:  Isabelle Lesur; Julien Textoris; Béatrice Loriod; Cécile Courbon; Stéphane Garcia; Marc Leone; Catherine Nguyen
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

8.  Inflammation impairs reverse cholesterol transport in vivo.

Authors:  Fiona C McGillicuddy; Margarita de la Llera Moya; Christine C Hinkle; Michelle R Joshi; Elise H Chiquoine; Jeffrey T Billheimer; George H Rothblat; Muredach P Reilly
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

Review 9.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

10.  Coarse particulate matter (PM2.5-10) affects heart rate variability, blood lipids, and circulating eosinophils in adults with asthma.

Authors:  Karin Yeatts; Erik Svendsen; John Creason; Neil Alexis; Margaret Herbst; James Scott; Lawrence Kupper; Ronald Williams; Lucas Neas; Wayne Cascio; Robert B Devlin; David B Peden
Journal:  Environ Health Perspect       Date:  2007-01-18       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.